"PBMs are avaricious middlemen, with a stranglehold ...

... on the prescription drug supply chain. Their scheme to sell formulary access for rebates drives up the cost of prescription drugs for the people who need to use them to stay alive."


— According to a class-action lawsuit that charges PBMs and pharmaceutical manufacturers with colluding to illegally raise prices of insulin.